Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Bruton's tyrosine kinase (BTK) inhibitors help treat relapsed or refractory Marginal Zone B-Cell Lymphomas / Marginal Zone Lymphomas (MZLs). Zanubrutinib is approved for adults with relapsed or refractory MZL. This is after they have tried at least one anti-CD20 treatment.
see also:
Marginal Zone B-Cell Lymphomas / Marginal Zone Lymphomas (MZLs) & Drugs/Treatments
[Tec‑family kinase inhibitors & Marginal Zone B-Cell Lymphomas / Marginal Zone Lymphomas (MZLs)](brain://M0…